BALAMINES.NS(BALAMINES.NS)
BALAMINES.NS
No analyst ratings available
No analyst price targets available for BALAMINES.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $18.85B | $25.02B | $27.54B |
| Low | $17.42B | $21.67B | $24.55B |
| High | $20.28B | $28.37B | $30.53B |
| EBITDA Avg | $4.13B | $5.92B | $6.48B |
| Low | $3.10B | $5.00B | $5.84B |
| High | $5.16B | $6.85B | $7.12B |
| EBIT Avg | $3.17B | $4.49B | $4.59B |
| Low | $2.14B | $3.56B | $3.95B |
| High | $4.20B | $5.41B | $5.22B |
| Net Income Avg | $2.09B | $2.97B | $3.04B |
| Low | $1.40B | $2.35B | $2.61B |
| High | $2.78B | $3.59B | $3.46B |
| EPS Avg | $64.55 | $91.75 | $93.80 |
| Low | $43.20 | $72.60 | $80.57 |
| High | $85.89 | $110.89 | $107.03 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 |